1758-2652

Journal of the International AIDS Society

Wiley (John Wiley & Sons)

View prefix report (10.1002)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 3086 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact3086 DOIs
2

Deposit reference lists for 1675 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact1675 DOIs
3

Add abstracts to 1279 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact1279 DOIs

DOIs for this ISSN

Showing the top 5 of 4207 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Putting episodic disability into context: a qualitative stud… (10.1186/1758-2652-2-5)
Abstract References ORCID License
164.35 43
2 The fields of HIV and disability: past, present and future (10.1186/1758-2652-2-3)
Abstract References ORCID License
130.10 19
3 Disability and HIV/AIDS - a systematic review of literature… (10.1186/1758-2652-2-9)
Abstract References ORCID License
130.10 19
4 Gender and sexuality: emerging perspectives from the heteros… (10.1186/1758-2652-13-6)
Abstract ORCID
128.29 367
5 The pharmacokinetic (PK) interaction between omeprazole and… (10.1186/1758-2652-11-s1-p239)
Abstract References ORCID License
127.88 18
6 The effect of food on ritonavir bioavailability following ad… (10.1186/1758-2652-11-s1-p247)
Abstract References ORCID License
127.88 18
7 Reimagining HIV service delivery: the role of differentiated… (10.7448/ias.19.1.21484)
Abstract ORCID
125.53 323
8 Transition of Thai HIV‐infected adolescents to adult HIV car… (10.7448/ias.18.1.20651)
Abstract References ORCID
112.89 31
9 O425 Efficacy and safety of maraviroc in treatment-experienc… (10.1186/1758-2652-11-s1-o47)
Abstract References ORCID License
104.14 10
10 Evidence for scale up: the differentiated care research agen… (10.7448/ias.20.5.22024)
Abstract ORCID
102.65 112
11 POWER 1 and 2: combined final 144-week efficacy and safety r… (10.1186/1758-2652-11-s1-p21)
Abstract References ORCID License
100.00 9
12 The UNAIDS 90–90–90 target: a clear choice for ending AIDS a… (10.7448/ias.19.1.21133)
Abstract ORCID
96.98 86
13 Oral abstracts of the 22nd International AIDS Conference, 23… (10.1002/jia2.25148)
Abstract References ORCID
95.91 18
14 O214 The FOTO study: 24-week results support the safety of a… (10.1186/1758-2652-11-s1-o19)
Abstract References ORCID License
95.42 8
15 HIV and adolescents: focus on young key populations (10.7448/ias.18.2.20076)
Abstract ORCID
91.94 68
16 Validation of an enhanced sensitivity Trofile™ HIV-1 co-rece… (10.1186/1758-2652-11-s1-p197)
Abstract References ORCID License
90.31 7
17 POWER 3 analysis: 144-week efficacy and safety results for d… (10.1186/1758-2652-11-s1-p24)
Abstract References ORCID License
90.31 7
18 Efficacy and safety by baseline HIV-RNA and CD4 count in tre… (10.1186/1758-2652-11-s1-p8)
Abstract References ORCID License
90.31 7
19 Oral abstracts of the 10th IAS Conference on HIV Science, 21… (10.1002/jia2.25327)
Abstract References ORCID
88.21 14
20 Measuring intersecting stigma among key populations living w… (10.1002/jia2.25131)
Abstract ORCID
87.79 56
21 Two years of Truvada for pre‐exposure prophylaxis utilizatio… (10.7448/ias.17.4.19730)
References ORCID
86.62 53
22 HIV Glasgow 2018, 28–31 October 2018, Glasgow, UK (10.1002/jia2.25187)
Abstract References ORCID
85.96 13
23 Abstract Supplement Oral Abstracts from the 23rd Internation… (10.1002/jia2.25547)
Abstract References ORCID
85.96 13
24 4th HIV Research for Prevention conference (HIVR4P // Virtua… (10.1002/jia2.25659)
Abstract References ORCID
85.96 13
25 Targeting 90–90–90 – don't leave children and adolescents be… (10.7448/ias.18.7.20745)
Abstract ORCID
83.14 45
26 Young key populations and HIV: a special emphasis and consid… (10.7448/ias.18.2.19438)
Abstract ORCID
82.66 44
27 Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow… (10.1002/jia2.26370)
Abstract References ORCID
80.94 11
28 Global action to reduce HIV stigma and discrimination (10.7448/ias.16.3.18893)
Abstract References ORCID
80.94 11
29 Factors associated with sex work involvement among transgend… (10.7448/ias.20.1.21422)
Abstract ORCID License
80.94 11
30 HIV Glasgow, 23–26 October 2022, Glasgow, UK / Virtual (10.1002/jia2.26009)
Abstract References ORCID
78.10 10
31 96 weeks pharmacoeconomic outcome of lopinavir/r monotherapy… (10.1186/1758-2652-11-s1-p308)
Abstract References ORCID License
77.82 5
32 Excellent short-term CD4 recovery with a PI- and NRTI-sparin… (10.1186/1758-2652-11-s1-p45)
Abstract References ORCID License
77.82 5
33 Selecting a viral load threshold for routine monitoring in r… (10.1002/jia2.25007)
Abstract ORCID
76.57 33
34 Once-daily S/GSK1349572 combination therapy in antiretrovira… (10.1186/1758-2652-13-s4-o50)
Abstract References ORCID
75.00 9
35 8th IAS Conference on HIV Pathogenesis, Treatment & Prev… (10.7448/ias.18.5.20479)
Abstract References ORCID
75.00 9
36 High rate of loss to clinical follow up among African HIV-in… (10.1186/1758-2652-13-29)
Abstract ORCID
73.86 29
37 Impact of HIV‐related stigma on treatment adherence: systema… (10.7448/ias.16.3.18640)
ORCID
73.57 876
38 Language, identity and HIV: why do we keep talking about the… (10.7448/ias.15.4.17990)
References ORCID
73.12 28
39 Condoms as evidence of prostitution in the United States and… (10.7448/ias.16.1.18626)
Abstract ORCID
73.12 28
40 The HIV epidemic and human rights violations in Brazil (10.7448/ias.16.1.18817)
Abstract ORCID
73.12 28
41 Predicted savings to the UK National Health Service from swi… (10.7448/ias.17.4.19497)
References ORCID
73.12 28
42 The effect of dolutegravir on the pharmacokinetics of metfor… (10.7448/ias.17.4.19584)
References ORCID
73.12 28
43 Development and evaluation of a clinical algorithm to monito… (10.1186/1758-2652-12-3)
Abstract ORCID
72.36 27
44 HIV Glasgow – Virtual, 5–8 October 2020 (10.1002/jia2.25616)
Abstract References ORCID
71.57 8
45 Oral abstracts of the 11th IAS Conference on HIV Science, 18… (10.1002/jia2.25755)
Abstract References ORCID
71.57 8
46 Abstract Supplement Abstracts from AIDS 2022 ‐ the 24th Inte… (10.1002/jia2.25935)
Abstract References ORCID
71.57 8
47 Abstract Supplement Abstracts from AIDS 2024, the 25th Inter… (10.1002/jia2.26279)
Abstract References ORCID
71.57 8
48 Lack of association between use of efavirenz and death from… (10.7448/ias.17.4.19512)
References ORCID
71.57 26
49 The political epidemiology of HIV (10.7448/ias.17.1.19327)
Abstract ORCID
70.75 25
50 Impact of HIV viral diversity and baseline resistance on tre… (10.1186/1758-2652-11-s1-p180)
Abstract References ORCID License
69.90 4